Regular Physical Inactivity and Ovarian Cancer Risk in the Ovarian Cancer in Women of African Ancestry Consortium

Sarah M. Lima & Heather M. Ochs-Balcom et al.

Abstract

Background:

Regular physical inactivity may increase ovarian cancer risk, but few studies have investigated whether this association is similar among Black and White women.

Methods:

In a pooled nested case–control study within the Ovarian Cancer in Women of African Ancestry consortium, logistic regression models evaluated regular recreational physical inactivity with risk of epithelial ovarian cancer among Black (223 cases; 1,472 controls) and White women (985 cases; 6,212 controls) enrolled in four cohort studies. Models were further stratified by histologic type.

Results:

Regular physical inactivity was not associated with the risk of overall ovarian cancer among Black [OR = 1.16; 95% confidence interval (CI), 0.83–1.61] or White women (OR = 1.03; 95% CI, 0.87–1.23). We did not detect associations according to histologic type.

Conclusions:

Physical inactivity was not associated with ovarian cancer among Black or White women in a consortium of cohort studies.

Impact:

These results are counter to case–control-based studies and emphasize the complexity of investigating physical activity prospectively.

Funding
An assessment of whether aspirin and/or vitamin D improves breast cancer outcomes in Black women and the modifying effect of genetic variantsCollaborative Genetic Study of Ovarian Cancer RiskA Follow-up Study for Causes of Illness in Black WomenCancer Research Training and Education CoordinationNHLBI NIH HHS Grant HHSN268201600004CThe Molecular Epidemiology Of Ovarian CancerNHLBI NIH HHS Grant HHSN268201600001CExploring factors related to racial disparities in ovarian cancer incidence and survival: the OCWAA consortiumSouthern Community Cohort StudyUnderstanding Population Differences in Cancer: The MEC StudyWomen's Health Initiative Cancer Survivor CohortNHLBI NIH HHS Grant HHSN268201600002CA Follow-up Study for Causes of Cancer in Black WomenNHLBI NIH HHS Grant HHSN268201600018CA Follow-up Study for Causes of Cancer in Black WomenNHLBI NIH HHS Grant HHSN268201600003CHormone Therapy and Risk of Ovarian CancerEpidemiology of Ovarian Cancer in African-American WomenA Follow-up Study for Causes of Cancer in Black WomenA Follow-up Study for Causes of Cancer in Black WomenA Follow-up Study for Causes of Illness in Black WomenNational Cancer Institute (NCI) Grant R01-CA61093National Cancer Institute (NCI) Grant P01-CA17054Collaborative Genetic Study of Ovarian Cancer RiskCancer Research Training and Education CoordinationWomen's Health Initiative Cancer Survivor CohortCalifornia Cancer Research Program Grant 2II0200The Molecular Epidemiology Of Ovarian CancerEpidemiology of Ovarian Cancer in African-American WomenNHLBI NIH HHS Grant HHSN268201600018CNHLBI NIH HHS Grant HHSN268201600001CNHLBI NIH HHS Grant HHSN268201600002CU.S. Department of Health and Human Services (HHS) Grant HHSN268201600003C and HHSN268201600004CNational Heart, Lung, and Blood Institute (NHLBI) Grant NIH/NHLBI-CSB-WH-2016-01-CMExploring factors related to racial disparities in ovarian cancer incidence and survival: the OCWAA consortiumAn assessment of whether aspirin and/or vitamin D improves breast cancer outcomes in Black women and the modifying effect of genetic variantsSouthern Community Cohort StudyU.S. Department of Health and Human Services Grant HHSN268201600018CU.S. Department of Health and Human Services Grant HHSN268201600001CU.S. Department of Health and Human Services Grant HHSN268201600002CSouthern Community Cohort StudyEpidemiology of Ovarian Cancer in African-American Women

NCI NIH HHS

K01 CA212056

NCI NIH HHS

R01 CA058598

NCI NIH HHS

R01 CA058420

NCI NIH HHS

P30 CA014089

NCI NIH HHS

R01 CA076016

NCI NIH HHS

R01 CA207260

NCI NIH HHS

U01 CA202979

NCI NIH HHS

U01 CA164973

NCI NIH HHS

UM1 CA173642

NCI NIH HHS

U01 CA164974

NCI NIH HHS

UM1 CA164974

NCI NIH HHS

P01 CA017054

NCI NIH HHS

R01 CA142081

National Institutes of Health (NIH)

UM1-CA164974

National Institutes of Health (NIH)

U01-CA164974

National Institutes of Health (NIH)

R01-CA058420

National Cancer Institute (NCI)

R01-CA058598

National Cancer Institute (NCI)

P30-CA014089

National Institutes of Health (NIH)

UM1-CA173642-05

National Cancer Institute (NCI)

R01-CA076016

National Cancer Institute (NCI)

R01-CA142081

National Institutes of Health (NIH)

R01-CA207260

National Institutes of Health (NIH)

K01-CA212056

National Institutes of Health

UM1-CA164974

National Institutes of Health

U01-CA164974

National Institutes of Health

R01-CA058420

National Cancer Institute

R01-CA058598

National Cancer Institute

P30-CA014089

National Institutes of Health

U01 CA202979

National Institutes of Health

UM1-CA173642-05

National Cancer Institute

R01-CA076016

National Cancer Institute

R01-CA142081

National Institutes of Health

R01-CA207260

National Institutes of Health

K01-CA212056